APELLIS PHARMACEUTICALS INC. - COMMON STOCK
30,77
22-ноября-24 15:44:58
15 мин. задержка
Акции
+3,02
+10,88%
Сегодняшний диапазон
27,71 - 30,99
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
07 май 2024 06:05:00 Источник Nasdaq GlobeNewswire
-
06 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
01 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
26 апр 2024 06:15:00 Источник Nasdaq GlobeNewswire
-
23 апр 2024 06:00:14 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 апр 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
01 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
11 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
27 фев 2024 06:05:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
26 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
20 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
26 янв 2024 06:06:23 Источник Nasdaq GlobeNewswire
-
Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues
08 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
28 дек 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Apellis Provides Update on Ongoing Regulatory Review of Pegcetacoplan for GA in the European Union
14 дек 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
11 дек 2023 06:00:00 Источник Nasdaq GlobeNewswire